Syntara Limited (ASX:SNT)
0.0320
+0.0010 (3.23%)
Mar 4, 2026, 1:09 PM AEST
Syntara Revenue
Syntara had revenue of 3.22M AUD in the half year ending December 31, 2025, with 415.04% growth. This brings the company's revenue in the last twelve months to 7.50M, down -8.02% year-over-year. In the fiscal year ending June 30, 2025, Syntara had annual revenue of 7.30M with 26.61% growth.
Revenue (ttm)
7.50M
Revenue Growth
-8.02%
P/S Ratio
6.97
Revenue / Employee
357.19K
Employees
21
Market Cap
52.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 7.30M | 1.53M | 26.61% |
| Jun 30, 2024 | 5.76M | -468.00K | -7.51% |
| Jun 30, 2023 | 6.23M | -9.52M | -60.45% |
| Jun 30, 2022 | 15.76M | -7.87M | -33.31% |
| Jun 30, 2021 | 23.63M | 11.01M | 87.28% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 129.24M |
| Vita Life Sciences | 93.27M |
| Medical Developments International | 40.64M |
| Little Green Pharma | 38.49M |
| ECS Botanics Holdings | 19.36M |
| IDT Australia | 19.00M |
| Peak Processing | 14.59M |
| Cann Group | 13.25M |